NPPA and cardiac hypertrophy: In db/db and ob/ob mice, empagliflozin improves LV diastolic function and reduces oxidative stress, mitochondrial dysfunction and ANP and BNP mRNA, although its effect on myocardial hypertrophy and fibrosis is unclear [91,166,167].